Deep Brain Stimulation Market Size, Share, Industry Trends and Forecast to 2030

Deep Brain Stimulation Market Size & CAGR in 2021

The deep brain stimulation market is expected to have a growth rate of 4.2% CAGR from 2021 to 2027. As a result, the market is anticipated to grow by USD 2.5 billion by 2027.

COVID-19 Impact on the Deep Brain Stimulation Market

The COVID-19 pandemic has significantly impacted the deep brain stimulation market. Due to lockdowns and restrictions, there was a delay in surgeries and procedures, leading to a temporary decline in the market. However, as restrictions ease and healthcare systems stabilize, the market is expected to recover gradually.

Deep Brain Stimulation Dynamics

Deep brain stimulation is a promising therapeutic approach for various neurological disorders, including Parkinson's disease, essential tremor, and dystonia. The market is driven by the increasing prevalence of these disorders, advancements in technology, and the growing demand for minimally invasive treatments.

Segments and Related Analysis

The deep brain stimulation market is segmented based on application, target region, and end-user. Parkinson's disease is the leading application segment, with a significant market share. Subthalamic nucleus is the most targeted region for deep brain stimulation, and hospitals are the primary end-users of these devices.

By Region Analysis

North America is the dominant region in the deep brain stimulation market, attributed to the presence of key market players, technological advancements, and high healthcare expenditure. Europe follows closely, with a growing aging population and increasing adoption of deep brain stimulation therapies.

Key Market Players and Competitive Landscape

Key market players in the deep brain stimulation market include Medtronic, Boston Scientific Corporation, Abbott Laboratories, and Aleva Neurotherapeutics. These companies focus on product innovation, strategic partnerships, and mergers to strengthen their market position.

Recent Happenings in the Deep Brain Stimulation Market

In recent developments, Medtronic announced the launch of a new deep brain stimulation system for the treatment of Parkinson's disease. Boston Scientific Corporation reported positive clinical trial results for its deep brain stimulation device in essential tremor patients. These advancements are expected to drive market growth and improve patient outcomes.